Biological Products: all 27 studies that test it
Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.
- Tumor-Specific T-Cells (cCTL:GL01) for Advanced Gastrointestinal CancerNot yet recruitingNCT07735065Phase 1
- Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA TreatmentRecruitingNCT07213323Not applicable
- Impact of IIT-SIT on Dengue ClustersRecruitingNCT06894901Not applicable
- An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney TransplantRecruitingNCT06832410Phase 3
- Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid TumorsRecruitingNCT05608148Phase 1
- Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological TherapyRecruitingNCT05169593Phase 4
- CD30 Targeted CAR-T in Treating CD30-Expressing LymphomasRecruitingNCT03383965Phase 1
- A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and LeukemiaRecruitingNCT03383952Phase 1
- A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate ADCompletedNCT05004688Phase 2Results posted
- Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy ChildrenCompletedNCT04816643Phase 3Results posted
- UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionTerminatedNCT02128230Phase 2Results posted
- Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic AdenocarcinomaTerminatedNCT01413087Phase 2Results posted
- A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT07010120Phase 1/2
- A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV VirusWithdrawnNCT06741982Phase 1
- A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple SclerosisActive, not recruitingNCT06451159Phase 1
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Active, not recruitingNCT06285643Phase 2
- Impact of Project Wolbachia - Singapore on Dengue IncidenceCompletedNCT05505682Not applicable
- Clinical Trial of GAIA-102 for Advanced and Relapse NSCLCTerminatedNCT05207371Phase 1/2
- Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 DiseaseCompletedNCT04542967Phase 2
- Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)CompletedNCT04436133Phase 2
- Validation of the In-utero Transmission of ProbioticsCompletedNCT04050189Phase 2
- Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA TrialWithdrawnNCT02587572Phase 2
- Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) TherapyStatus unknownNCT01947569Phase 1/2
- Human Safety of Capsaicin Inhalation Challenge Testing for Young and Older MenCompletedNCT01621685Phase 1
- Biological Meshes in Infected Fields: a Randomized Controlled TrialCompletedNCT01594450Phase 3
- Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast VaginitisStatus unknownNCT00479947Phase 1
- Collagenase in the Treatment of CelluliteStatus unknownNCT00261144Phase 2